Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study

References

1. 1.↵
   1. Brann DH,
   2. Tsukahara T,
   3. Weinreb C, et al

   . Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 2020;6:eabc5801 doi:10.1126/sciadv.abc5801 pmid:32937591

   FREE Full Text
2. 2.↵
   1. Li YC,
   2. Bai WZ,
   3. Hirano N, et al

   . Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer and the early response of satellite cells. Virus Res 2012;163:628–35 doi:10.1016/j.virusres.2011.12.021 pmid:22248641

   CrossRefPubMed
3. 3.↵
   1. Baig AM,
   2. Khaleeq A,
   3. Ali U, et al

   . Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995–98 doi:10.1021/acschemneuro.0c00122 pmid:32167747

   CrossRefPubMed
4. 4.↵
   1. Li YC,
   2. Bai WZ,
   3. Hashikawa T

   . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92:552–55 doi:10.1002/jmv.25728 pmid:32104915

   CrossRefPubMed
5. 5.↵
   1. Aggarwal G,
   2. Lippi G,
   3. Henry BM

   . Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 2020;15:385–89 doi:10.1177/1747493020921664 pmid:32310015

   CrossRefPubMed
6. 6.↵
   1. Parauda SC,
   2. Gao V,
   3. Gewirtz AN, et al

   . Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci 2020;416:117019 doi:10.1016/j.jns.2020.117019 pmid:32679347

   CrossRefPubMed
7. 7.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
8. 8.↵
   1. Altunisik E,
   2. Sayiner HS,
   3. Aksoz S, et al

   . Neurological symptoms in COVID-19 patients. Bratisl Lek Listy 2021;122:39–44 doi:10.4149/BLL_2021_004 pmid:33393319

   CrossRefPubMed
9. 9.↵
   1. Sedaghat AR,
   2. Gengler I,
   3. Speth MM

   . Olfactory dysfunction: a highly prevalent symptom of COVID-19 with public health significance. Otolaryngol Head Neck Surg 2020;163:12–15 doi:10.1177/0194599820926464 pmid:32366160

   CrossRefPubMed
10. 10.↵
    1. Lechien JR,
    2. Chiesa-Estomba CM,
    3. De Siati DR, et al

    . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19); a multicenter European study. Eur Arch Otorhinolaryngol 2020;277:2251–61 doi:10.1007/s00405-020-05965-1 pmid:32253535

    CrossRefPubMed
11. 11.↵
    1. Klopfenstein T,
    2. Kadiane-Oussou NJ,
    3. Toko L, et al

    . Features of anosmia in COVID-19. Med Mal Infect 2020;50:436–39 doi:10.1016/j.medmal.2020.04.006 pmid:32305563

    CrossRefPubMed
12. 12.↵
    1. Wölfel R,
    2. Corman VM,
    3. Guggemos W, et al

    . Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581:465–69 doi:10.1038/s41586-020-2196-x pmid:32235945

    CrossRefPubMed
13. 13.↵
    1. Jafek BW,
    2. Murrow B,
    3. Michaels R, et al

    . Biopsies of human olfactory epithelium. Chem Senses 2002;27:623–28 doi:10.1093/chemse/27.7.623 pmid:12200342

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Cömert A,
    2. Kahiloğulları G,
    3. Cömert E, et al

    . Bulbus Olfactorius, Tractus Olfactorius, Sulcus Olfactorius ve Trigonum Olfactorium Morfometrisi: Anatomik Çalışma. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2009;62:149–52
15. 15.↵
    1. Yousem DM,
    2. Geckle RJ,
    3. Bilker WB,
    4. Doty RL

    . Olfactory bulb and tract and temporal lobe volumes. Normative data across decades. Ann N Y Acad Sci 1998;855:546–55 doi:10.1111/j.1749-6632.1998.tb10624.x pmid:9929650

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Altunisik E,
    2. Baykan AH

    . Comparison of the olfactory bulb volume and the olfactory tract length between patients diagnosed with essential tremor and healthy controls: findings in favor of neurodegeneration. Cureus 2019;11:e5846 doi:10.7759/cureus.5846 pmid:31754581

    CrossRefPubMed
17. 17.↵
    1. Altunisik E,
    2. Baykan AH

    . Decreased olfactory bulb volume in patients with restless legs syndrome. Anatolian Journal of Psychiatry 2020;21:537–43
18. 18.↵
    1. Cullu N,
    2. Yeniçeri IO,
    3. Guney B, et al

    . Evaluation of olfactory bulbus volume and olfactory sulcus depth by 3 T MR. Surg Radiol Anat 2020;42:1113–18 doi:10.1007/s00276-020-02484-w pmid:32377954

    CrossRefPubMed
19. 19.↵
    1. Hummel T,
    2. Witt M,
    3. Reichmann H, et al

    . Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson’s disease. J Neurol Sci 2010;289:119–22 doi:10.1016/j.jns.2009.08.026 pmid:19775703

    CrossRefPubMed
20. 20.↵
    1. Sahin S,
    2. Baykan AH,
    3. Altunisik E, et al

    . Quantitative analysis of healthy olfactory sulcus depth, olfactory tract length and olfactory bulb volume in the pediatric population: a magnetic resonance study. Folia Morphol (Warsz) 2021;80:33–39 doi:10.5603/FM.a2020.0125 pmid:33084007

    CrossRefPubMed
21. 21.↵
    1. Rombaux P,
    2. Duprez T,
    3. Hummel T

    . Olfactory bulb volume in the clinical assessment of olfactory dysfunction. Rhinology 2009;47:3–9 pmid:19382487

    PubMedWeb of Science
22. 22.↵
    1. Duprez TP,
    2. Rombaux P

    . Imaging the olfactory tract (cranial nerve 1). Eur J Radiol 2010;74:288–98 doi:10.1016/j.ejrad.2009.05.065 pmid:20303227

    CrossRefPubMed
23. 23.↵
    1. Schneider JF,
    2. Floemer F

    . Maturation of the olfactory bulbs: MR imaging findings. AJNR Am J Neuroradiol 2009;30:1149–52 doi:10.3174/ajnr.A1501 pmid:19279285

    Abstract/FREE Full Text
24. 24.↵
    1. Chen S,
    2. Tan Hy,
    3. Wu Zh, et al

    . Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson’s disease and multiple system atrophy. Eur J Radiol 2014;83:564–70 doi:10.1016/j.ejrad.2013.11.024 pmid:24360232

    CrossRefPubMed
25. 25.↵
    1. Welge-Lussen A,
    2. Wolfensberger M

    . Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol 2006;63:125–32 doi:10.1159/000093758 pmid:16733337

    CrossRefPubMed
26. 26.↵
    1. Jalessi M,
    2. Barati M,
    3. Rohani M, et al

    . Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19. Neurol Sci 2020;41:2331–38 doi:10.1007/s10072-020-04590-4 pmid:32656713

    CrossRefPubMed
27. 27.↵
    1. Cooper KW,
    2. Brann DH,
    3. Farruggia MC, et al

    . COVID-19 and the chemical senses: supporting players take center stage. Neuron 2020;107:219–33 doi:10.1016/j.neuron.2020.06.032 pmid:32640192

    CrossRefPubMed
28. 28.↵
    1. Twomey JA,
    2. Barker CM,
    3. Robinson G, et al

    . Olfactory mucosa in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 1979;42:983–87 doi:10.1136/jnnp.42.11.983 pmid:228010

    Abstract/FREE Full Text
29. 29.↵
    1. Chiu A,
    2. Fischbein N,
    3. Wintermark M, et al

    . COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology 2021;63:147–48 doi:10.1007/s00234-020-02554-1 pmid:32930820

    CrossRefPubMed
30. 30.↵
    1. Laurendon T,
    2. Radulesco T,
    3. Mugnier J, et al

    . Bilateral transient olfactory bulb edema during COVID-19–related anosmia. Neurology 2020;95:224–25 doi:10.1212/WNL.0000000000009850 pmid:32444492

    CrossRefPubMed
31. 31.↵
    1. Tsivgoulis G,
    2. Fragkou PC,
    3. Lachanis S, et al

    . Olfactory bulb and mucosa abnormalities in persistent COVID-19 induced anosmia: a magnetic resonance imaging study. Eur J Neurol 2021;1:6–8 doi:10.1111/ene.14537 pmid:32939911

    CrossRefPubMed
32. 32.↵
    1. Li CW,
    2. Syue LS,
    3. Tsai YS, et al

    . Anosmia and olfactory tract neuropathy in a case of COVID-19. J Microbiol Immun Infect 2021;54:93–96 doi:10.1016/j.jmii.2020.05.017 pmid:32576457

    CrossRefPubMed
33. 33.↵
    1. Chetrit A,
    2. Lechien JR,
    3. Ammar A, et al

    . Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: preliminary prospective study. J Infect 2020;81:816–46 doi:10.1016/j.jinf.2020.07.028 pmid:32739489

    CrossRefPubMed
34. 34.↵
    1. Aragão MF,
    2. Leal MC,
    3. Filho OC, et al

    . Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI. AJNR Am J Neuroradiol 2020;41:1703–06 doi:10.3174/ajnr.A6675 pmid:32586960

    Abstract/FREE Full Text
35. 35.↵
    1. Politi LS,
    2. Salsano E,
    3. Grimaldi M

    . Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol 2020;77:1028–29 doi:10.1001/jamaneurol.2020.2125 pmid:32469400

    CrossRefPubMed
36. 36.↵
    1. Karimi-Galougahi M,
    2. Yousefi-Koma A,
    3. Bakhshayeshkaram M, et al

    . ¹⁸FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad Radiol 2020;27:1042–43 doi:10.1016/j.acra.2020.04.030 pmid:32386948

    CrossRefPubMed